The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Transcriptional Cross Talk between NF-κB and p53
Open accessAbstract
Many cellular stimuli result in the induction of both the tumor suppressor p53 and NF-kappaB. In contrast to activation of p53, which is associated with the induction of apoptosis, stimulation of NF-kappaB has been shown to promote resistance to programmed cell death. These observations suggest that a regulatory mechanism must exist to integrate these opposing outcomes and coordinate this critical cellular decision-making event. Here we show that both p53 and NF-kappaB inhibit each other's ability to stimulate gene expression and that this process is controlled by the relative levels of each transcription factor. Expression of either wild-type p53 or the RelA(p65) NF-kappaB subunit suppresses stimulation of transcription by the other factor from a reporter plasmid in vivo. Moreover, endogenous, tumor necrosis factor alpha-activated NF-kappaB will inhibit endogenous wild-type p53 transactivation. Following exposure to UV light, however, the converse is observed, with p53 downregulating NF-kappaB-mediated transcriptional activation. Both p53 and RelA(p65) interact with the transcriptional coactivator proteins p300 and CREB-binding protein (CBP), and we demonstrate that these results are consistent with competition for a limiting pool of p300/CBP complexes in vivo. These observations have many implications for regulation of the transcriptional decision-making mechanisms that govern cellular processes such as apoptosis. Furthermore, they suggest a previously unrealized mechanism through which dysregulated NF-kappaB can contribute to tumorigenesis and disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Since p53 inhibits RELA by competing for CBP binding (Webster and Perkins, 1999), p53 likely limits the IL1 arm of the SASP by reducing NF-κB activity.”
From Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype (2016) · cites this paper as Webster and Perkins, 1999
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,262
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 5,882
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047
Wang, C.-Y., Mayo, M., Korneluk, R., Goeddel, D., & Baldwin, A. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,950
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,586
Suppression of TNF-α-Induced Apoptosis by NF-κB
Antwerp, D. J. V., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
A model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Flagged first, then by citations
Research works printed but not linked: 11
- Bannister A. J., 1995, Oncogene, 11, 2509
- Eck S. L., 1993, Mol. Cell. Biol., 13, 6530
- el-Deiry W. S., 1994, Cancer Res., 54, 1169
- 10.1073/pnas.94.4.1074 · DOI
- Israel A., 1997, Nature, 388, 519
- Jiang H., 1994, Oncogene, 9, 3397
- Mukhopadhyay T., 1996, Int. J. Oncol., 9, 715
- Perkins N. D., 1994, Mol. Cell. Biol., 14, 6570
- Ravi R., 1998, Cancer Res., 58, 4531
- Stein B., 1993, Mol. Cell. Biol., 13, 3964
- Vojtesek B., 1995, Oncogene, 10, 389
Cited by
Sorted by citations
Items 401–500 of 600
Role of NF-kB, p53, and p21 in the Regulation of TNF-α Mediated Apoptosis of Lymphocytes
Ryazantsevа, N. V., Новицкий, В. В., Жукова, О. Б., Biktasova, A. K., Чечина, О. Е., Sazonova, E. V., Тимофеевна, Р. Т., Wice, A. N., & Chasovskikh, N. Y. (2010) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-010-0873-8 · Cited by 20
Fukuda, R.-I., Tsuchiya, K., Suzuki, K. A. O., Itoh, K., Fujita, J., Utsunomiya, A., & Tsuji, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806325200 · Cited by 20
RetractedBanerjee, K., Ganguly, A., Chakraborty, P., Sarkar, A., Singh, S., Chatterjee, M., Bhattacharya, S., & Choudhuri, S. K. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.11.009 · Cited by 20
HEY1 functions are regulated by its phosphorylation at Ser-68
López-Mateo, I., Arruabarrena-Aristorena, A., Artaza‐Irigaray, C., López, J. A., Calvo, E., & Belandia, B. (2016) · Bioscience Reports · doi:10.1042/bsr20160123 · Cited by 20
Cai, Q., Tu, M., Xu-Monette, Z. Y., Sun, R., Manyam, G. C., Xu, X., Tzankov, A., Hsi, E. D., Møller, M. B., Medeiros, L. J., et al. (2017) · Modern Pathology · doi:10.1038/modpathol.2017.5 · Cited by 22
Sengupta, S., Ghufran, S. M., Khan, A. A., Biswas, S., & Roychoudhury, S. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02831-4 · Cited by 20
Transcriptional activation of APAF1 by KAISO (ZBTB33) and p53 is attenuated by RelA/p65
Koh, D., An, H., Kim, M., Jeon, B., Choi, S., Hur, S. S., & Hur, M. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.07.008 · Cited by 20
Nanda, N., Dhawan, D. K., Bhatia, A., Mahmood, A., & Mahmood, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151539 · Cited by 20
Vlachostergios, P. J., Patrikidou, A., Daliani, D., & Papandreou, C. N. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00825.x · Cited by 22
Cross-Regulation of T Cell Growth Factor Expression by p53 and the Tax Oncogene
Chaudhry, S., Freebern, W. J., Smith, J. L., Butscher, W. G., Haggerty, C. M., & Gardner, K. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.6767 · Cited by 20
Coleman, K.-L., Chiaramonti, M., Haddad, B., Ranzenberger, R., Henning, H., Khashali, H. A., Ray, R., Darweesh, B., Guthrie, J. W., Heyl, D., et al. (2023) · Cells · doi:10.3390/cells12030405 · Cited by 19
Antitumor mechanism of cannabidiol hidden behind cancer hallmarks
Yan, C., Li, Y., Liu, H., Chen, D., & Wu, J. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188905 · Cited by 19
Co-expression of RelA/p65 and ACTN4 induces apoptosis in non-small lung carcinoma cells
Lomert, E. V., Turoverova, L. V., Kriger, D. V., Aksenov, N. D., Nikotina, A. D., Petukhov, A., Mittenberg, A. G., Panyushev, N. V., Георгиевич, Х. М., Volkov, K. V., et al. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1417709 · Cited by 19
Dorandish, S., Atali, S., Ray, R., Khashali, H. A., Coleman, K.-L., Guthrie, J. W., Heyl, D., & Evans, H. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137059 · Cited by 19
Huang, W.-F., Cao, Y., Liu, Y., Feng, P., Shang, J., Zhang, Z., & Li, Y. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27951 · Cited by 19
The Large Subunit of Replication Factor C Interacts with the Histone Deacetylase, HDAC1
Anderson, L. A., & Perkins, N. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200513200 · Cited by 19
Self-citationContext-dependent Pax-5 repression of a PU.1/NF-κB regulated reporter gene in B lineage cells
Linderson, Y., French, N. S., Neurath, M. F., & Pettersson, S. (2001) · Gene · doi:10.1016/s0378-1119(00)00546-1 · Cited by 19
Studies on modulation of the activity of tumor suppressor protein p53
Kadaja, L. (2004) · DSpace repository (University of Tartu) · Cited by 19
Liang, Y., Chen, G., Yang, Y., Li, Z., Chen, T., Sun, W., Yu, M., Pan, K., Guo, W., & Tian, W. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1252-7 · Cited by 18
Chen, P.-M., Wu, T., Cheng, Y., Chen, C., & Lee, H. (2015) · Oncotarget · doi:10.18632/oncotarget.3695 · Cited by 18
Rinehart, J. J., Keville, L., Neidhart, J., Wong, L., DiNunno, L., Kinney, P., Aberle, M., Tadlock, L., & Cloud, G. (2003) · American Journal of Clinical Oncology · doi:10.1097/01.coc.0000027268.23258.7d · Cited by 18
Smartt, H. J. M., Elder, D. J. E., Hicks, D. J., Williams, N., & Paraskeva, C. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601266 · Cited by 18
Lelièvre, S. A., Bisseil, M. J., & Pujuguet, P. (2000) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v10.i1.30 · Cited by 18
Kennedy, J., Mémet, S., & Wells, P. G. (2004) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)05622-0 · Cited by 18
Jin, Y., Li, Y., Wang, X., & Yang, Y. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0942-7 · Cited by 17
Inflammation-associated genomic instability in cancer
Pua, K. H., Chew, C. L., Lane, D. P., & Tergaonkar, V. (2019) · Genome Instability & Disease · doi:10.1007/s42764-019-00006-6 · Cited by 17
Coactivator requirements for p53‐dependent transcription in the yeast Saccharomyces cerevisiae
Yousef, A. F., Xu, G. W., Mendez, M., Brandl, C. J., & Mymryk, J. S. (2007) · International Journal of Cancer · doi:10.1002/ijc.23174 · Cited by 17
Szołtysek, K., Pietranek, K., Kalinowska, M., Pietrowska, M., Kimmel, M., & Widłak, P. (2008) · Acta Biochimica Polonica · doi:10.18388/abp.2008_3035 · Cited by 17
Sztalmachová, M., Hlavna, M., Gumulec, J., Holubová, M., Babula, P., Balvan, J., Sochor, J., Tanhäuserová, V., Raudenská, M., Křížková, S., et al. (2012) · Oncology Reports · doi:10.3892/or.2012.1897 · Cited by 17
Role of peroxidases, thiols and Bak/Bax in tumor cell susceptibility to Cu[DEDTC]2
Viola-Rhenals, M., RIEBER, M. S., & Rieber, M. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.048 · Cited by 17
Prognostic Significance of theBIRC2-BIRC3Gene Signature in Head and Neck Squamous Cell Carcinoma
Lee, M. K., Noh, J. K., Woo, S. R., Kong, M., Lee, Y. C., Lee, J. W., Ko, S., & Eun, Y. (2022) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20344 · Cited by 16
Diverse roles of UBE2S in cancer and therapy resistance: Biological functions and mechanisms
Zhang, M., Wang, J., Zhang, Z., Guo, Y., Lou, X., & Zhang, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24465 · Cited by 16
p53 functions and cell lines: Have we learned the lessons from the past?
Millau, J., Mai, S., Bastien, N., & Drouin, R. (2010) · BioEssays · doi:10.1002/bies.200900160 · Cited by 16
Salomón, R., Furones, M. D., Reyes‐López, F. E., Tort, L., Firmino, J. P., Esteban, M. Á., Espinosa‐Ruíz, C., Quintela, J. C., Pinilla-Rosas, J. M., Vallejos‐Vidal, E., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.737601 · Cited by 16
Veuger, S. J., & Durkacz, B. W. (2010) · DNA repair · doi:10.1016/j.dnarep.2010.11.005 · Cited by 16
P53, Cell Cycle Arrest and Apoptosis
Wang, S., & El‐Deiry, W. S. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_6 · Cited by 17
Chen, L. I., Sommer, K. M., & Swisshelm, K. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202717200 · Cited by 16
Bellarosa, D., Binaschi, M., Maggi, C. A., & Goso, C. (2005) · PubMed · Cited by 16
Szabó, L. G., Molnár, R., Tomesz, A., Deutsch, A., Darago, R., Varjas, T., Ritter, Z., Szentpéteri, J. L., Andreidesz, K., Máthé, D., et al. (2022) · Nutrients · doi:10.3390/nu14040908 · Cited by 15
Malyukova, A., Lahnalampi, M., Falqués, T., Pölönen, P., Sipola, M., Mehtonen, J., Teppo, S., Akopyan, K., Viiliäinen, J., Lohi, O., et al. (2024) · Genome biology · doi:10.1186/s13059-024-03260-4 · Cited by 15
Lin, Y., Clair, J. M., Luo, J., Sharma, S. P., Dubinett, S. M., & John, M. A. S. (2015) · Oral Oncology · doi:10.1016/j.oraloncology.2015.07.006 · Cited by 15
Pulsed Electric Fields Alter Expression of NF-κB Promoter-Controlled Gene
Kavaliauskaitė, J., Kazlauskaitė, A., Lazutka, J. R., Mozoļevskis, G., & Stirkė, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010451 · Cited by 15
Parthenolide complements the cell death-inducing activity of doxorubicin in melanoma cells.
Woźniak, M., Szuławska‐Mroczek, A., Hartman, M. L., Nejc, D., & Czyż, M. (2013) · PubMed · Cited by 15
Rudolf, E., & Červinka, M. (2008) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2007.12.003 · Cited by 15
Up-regulation of NFκB-responsive gene expression by ΔNp73α in p53 null cells
Tanaka, Y., Ota, K., Kameoka, M., Itaya, A., & Yoshihara, K. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.12.013 · Cited by 15
Kim, H., Lee, S. H., Lee, M.-N., Oh, G. T., Choi, K., & Choi, E. Y. (2013) · Oncotarget · doi:10.18632/oncotarget.1318 · Cited by 15
Mutant p53 reactivator SLMP53-2 hinders ultraviolet B radiation-induced skin carcinogenesis
Loureiro, J. B., Ribeiro, R. S. R., Nazareth, N., Ferreira, T., Lopes, E. A., Gama, A., Machuqueiro, M., Alves, M. G., Marabini, L., Oliveira, P. A., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.106026 · Cited by 14
Lee, S., Kim, D.-Y., KANG, Y.-Y., Kim, H., JANG, J., LEE, M.-N., Oh, G. T., Kang, S., & Choi, E. Y. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1645 · Cited by 14
Tanaka, T., Nakano, T., Hozumi, Y., Martelli, A. M., & Goto, K. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.118953 · Cited by 15
p300 expression is induced by oxygen deficiency and protects neuron cells from damage
Tan, X. L., Zhai, Y., Gao, W. X., Fan, Y. M., Liu, F. Y., Huang, Q. Y., & Gao, Y. Q. (2008) · Brain Research · doi:10.1016/j.brainres.2008.11.092 · Cited by 14
Dhanisha, S. S., Drishya, S., & Guruvayoorappan, C. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.112816 · Cited by 13
Regulation of CXCR4 gene expression in breast cancer cells under diverse stress conditions
Andreou, K. E., Rajendran, R., Krstic–Demonacos, M., & Demonacos, C. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1643 · Cited by 13
Molecular Dynamics in Esophageal Adenocarcinoma: Who’s in Control?
Dang, T., & Chai, J. (2020) · Current Cancer Drug Targets · doi:10.2174/1568009620666200720011341 · Cited by 13
Galley, J. D., Mar, P. K., Wang, Y., Han, R., Rajab, A., & Besner, G. E. (2021) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2021.02.016 · Cited by 14
Meng, A., Yu, T., Chen, G., Brown, S. A., Wang, Y., Thompson, J. S., & Zhou, D. (2003) · International Journal of Radiation Biology · doi:10.1080/09553000310001622814 · Cited by 13
Catizone, A. N., Good, C. R., Alexander, K. A., Berger, S. L., & Sammons, M. A. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1593643 · Cited by 12
Signaling through TLR5 mitigates lethal radiation damage by neutrophil-dependent release of MMP-9
Brackett, C. M., Greene, K. F., Aldrich, A., Trageser, N. H., Pal, S., Molodtsov, I. A., Kandar, B. M., Burdelya, L. G., Abrams, S. I., & Gudkov, A. V. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00642-6 · Cited by 12
Reduction of lithium induced interstitial fibrosis on co-administration with amiloride
Mehta, P. M., Gimenez, G., Walker, R. J., & Slatter, T. L. (2022) · Scientific Reports · doi:10.1038/s41598-022-18825-1 · Cited by 12
Jia, K., Xiong, H., Yuan, W., Huang, L., Xu, J., Lu, C., Hu, Y., Huang, K., Luo, Q., Ma, J., et al. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.108672 · Cited by 12
Regulation of apoptosis in the female reproductive system
Vaskivuo, T. E. (2002) · Cited by 12
NF-κB prevents cells from undergoing Cr(VI)-induced apoptosis
Wang, S., Chen, F., Zhang, Z., Shi, X., Jiang, B., & Luo, J. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000007269.74532.98 · Cited by 12
Masre, S. F., Rath, N., Olson, M. F., & Greenhalgh, D. A. (2016) · Oncogene · doi:10.1038/onc.2016.402 · Cited by 12
Khashali, H. A., Darweesh, B., Ray, R., Haddad, B., Wozniak, C., Ranzenberger, R., Goel, S., Khalil, J., Guthrie, J. W., Heyl, D., et al. (2023) · Cancers · doi:10.3390/cancers15235500 · Cited by 11
TAK1 signaling regulates p53 through a mechanism involving ribosomal stress
Zonneville, J., Wong, V., Limoge, M., Nikiforov, M. A., & Bakin, A. V. (2020) · Scientific Reports · doi:10.1038/s41598-020-59340-5 · Cited by 12
Kong, E. Y., Choi, V. W. Y., Cheng, S. H., & Yu, K. N. (2014) · International Journal of Radiation Biology · doi:10.3109/09553002.2014.932031 · Cited by 11
Zhou, Y., Li, G., Ji, Y., Liu, C., Zhu, J., & Lu, Y. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-15 · Cited by 11
Inflammation-Related Pancreatic Carcinogenesis
Dai, J., Jiang, M., Wang, X., & Tian, L. (2017) · Pancreas · doi:10.1097/mpa.0000000000000886 · Cited by 11
Maurya, N., Agarwal, N. R., & Ghosh, I. (2015) · Cell Biology International · doi:10.1002/cbin.10561 · Cited by 11
Popović, K. J., Popović, D. J., Miljković, D., Popović, J. K., Lalošević, D., Poša, M., & Čapo, I. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112168 · Cited by 10
Harada, M., Su-Harada, K., Kimura, T., Ono, K., & Ashida, N. (2024) · Cell Cycle · doi:10.1080/15384101.2024.2325802 · Cited by 10
Gasparian, A. V., Fedorova, M. D., & Kisseljov, F. L. (2007) · Biochemistry (Moscow) · doi:10.1134/s0006297907080068 · Cited by 10
Li, Y., Yu, Y., Zhang, Y., Zhou, Y., Li, C., Zhu, J., Yuan, H., & Lü, H. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02061.x · Cited by 10
Cellular response of blood and hepatic tissue to gamma irradiation
Mohamed, M. A., Saeid, A. A. E., & Ahmed, M. A. (2015) · Journal of Radiation Research and Applied Sciences · doi:10.1016/j.jrras.2015.12.001 · Cited by 10
Nuclear factor κB signaling revisited: Its role in skeletal muscle and exercise
Ji, L. L. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.02.013 · Cited by 9
Inflammatory signaling in the pathogenesis of acute myeloid leukemia
Baumann, A., & Ellegast, J. M. (2025) · HemaSphere · doi:10.1002/hem3.70188 · Cited by 9
NF-κB/p52 augments ETS1 binding genome-wide to promote glioma progression
Sim, N., & Li, Y. (2023) · Communications Biology · doi:10.1038/s42003-023-04821-2 · Cited by 9
Constitutive IL-8 expression in cancer cells is associated with mutation of p53.
Hidaka, H., Ishiko, T., Ishikawa, S., Ikeda, O., Mita, S., Iwamura, T., Chijiiwa, K., & Ogawa, M. (2005) · PubMed · Cited by 9
Jones, R. D., Qian, Y., Siciliano, V., DiAndreth, B., Huh, J. H., Weiss, R., & Vecchio, D. D. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/867028 · Cited by 9
Metselaar, D. S., Meel, M. H., Goulding, J. R., du Chatinier, A., Rigamonti, L., Waranecki, P., Geisemeyer, N., de Gooijer, M. C., Breur, M., Köster, J., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101700 · Cited by 8
Nešić, D., Grumont, R. J., & Gerondakis, S. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2125 · Cited by 8
Suri, S., Mirza, M. A., Anwer, M. K., Alshetaili, A., Alshahrani, S. M., Ahmed, F. J., & Iqbal, Z. (2019) · Journal of Polymer Engineering · doi:10.1515/polyeng-2018-0169 · Cited by 8
Kaur, N., Ranjan, A., Tiwari, V., Aneja, R., & Tandon, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039426 · Cited by 8
RetractedAnti-inflammatory and Proapoptotic Properties of the Natural Compound o-Orsellinaldehyde
Tomas‐Hernández, S., Garcı́a-Vallvé, S., Pujadas, G., Valls, C., Ojeda, M. J., Gimeno, A., Cereto‐Massagué, A., Roca‐Martínez, J., Suárez, M., Arola, L., et al. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b00782 · Cited by 8
Noman, A. S. M., Koide, N., Iftakhar-E-Khuda, I., Dagvadorj, J., Tumurkhuu, G., Naiki, Y., Komatsu, T., Yoshida, T., & Yokochi, T. (2010) · Cellular Immunology · doi:10.1016/j.cellimm.2010.05.007 · Cited by 8
Long, A. A., Chapman, N., Innes, B. A., Europe‐Finner, G. N., & Robson, S. C. (2004) · Journal of the Society for Gynecologic Investigation · doi:10.1016/j.jsgi.2004.10.012 · Cited by 8
Camarda, G., Binaschi, M., Maggi, C. A., & Goso, C. (2002) · International Journal of Cancer · doi:10.1002/ijc.10745 · Cited by 8
Adib, M., Taghadosi, M., Tahmasebi, M. N., Vaziri, A. S., Jamshidi, A., Mahmoudi, M., & Farhadi, E. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01094-9 · Cited by 7
Nuclear iASPP determines cell fate by selectively inhibiting either p53 or NF-κB
Ge, W., Wang, Y., Zheng, S., Zhao, D. H., Wang, X., Zhang, X., & Hu, Y. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00582-1 · Cited by 7
Breathe it in – Spotlight on senescence and regeneration in the lung
Majewska, J., & Krizhanovsky, V. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111550 · Cited by 7
NF- κ B and chemoresistance: could NF- κ B be an antitumor target?
Bentires‐Alj, M., Merville, M., & Bours, V. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0093 · Cited by 7
β‐Adrenergic Signaling Promotes Anti‐Tumor Immunity in TP53‐mutant Oral Squamous Cell Carcinoma
Gleber‐Netto, F. O., Silverman, D. A., Xie, T., Akhter, S., Vaughn, N. R., Adebayo, A. A., Debnath, K. C., Na’ara, S., Islam, S., Knutsen, E., et al. (2026) · Advanced Science · doi:10.1002/advs.202516859 · Cited by 6
A Primer on the Role of TP53 Mutation and Targeted Therapy in Endometrial Cancer
Zhang, B., Zhang, H., & Qin, Y. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl25447 · Cited by 6
Wang, J., Zheng, Z., Cui, X., Dai, C., Li, J., Zhang, Q., Cheng, M., & Jiang, F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.926317 · Cited by 6
Deficient Radiation Transcription Response in COVID-19 Patients
Polozov, S., Cruz-Garcia, L., O’Brien, G., Goriacha, V., Nasser, F., Jeggo, P. A., Candéias, S. M., & Badie, C. (2023) · Advances in Radiation Oncology · doi:10.1016/j.adro.2023.101215 · Cited by 6
Elucidation of functional consequences of signalling pathway interactions
Ihekwaba, A., Nguyen, P. T., & Priami, C. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-370 · Cited by 6
An IKK/NF-κB Activation/p53 Deletion Sequence Drives Liver Carcinogenesis and Tumor Differentiation
Svinarenko, M., Katz, S., Tharehalli, U., Mulaw, M. A., Maier, H. J., Sunami, Y., Fischer, S. K., Chen, Y., Heurich, S., Erkert, L., et al. (2019) · Cancers · doi:10.3390/cancers11101410 · Cited by 6
Александровна, П. Е., Ivanov, V. V., Pershina, A. G., Perekucha, N. A., Dzyuman, A. N., Kaminskii, I. P., Saltykova, I. V., Сазонов, А. Э., & Ogorodova, L. M. (2019) · Acta Tropica · doi:10.1016/j.actatropica.2019.01.017 · Cited by 6
Masre, S. F., Rath, N., Olson, M. F., & Greenhalgh, D. A. (2020) · Carcinogenesis · doi:10.1093/carcin/bgz205 · Cited by 6
Zając, G., Rusin, M., Łasut-Szyszka, B., Puszyński, K., & Widłak, P. (2022) · Acta Biochimica Polonica · doi:10.18388/abp.2020_5942 · Cited by 6
Rath, P. C., & Mukhopadhyay, T. K. (2009) · DNA and Cell Biology · doi:10.1089/dna.2008.0839 · Cited by 6
Metadata
- Authors
- Webster, G. A., & Perkins, N. D.
- Affiliations
- University of Dundee (GB)
- ORCID
- Perkins, Neil D.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1999-05-01
- Volume
- 19
- Issue
- 5
- Pages
- 3485-3495
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC84141
- OpenAlex
- W2134542375
- Cited by
- 598
- References
- 87
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 12 · 2023: 13 · 2022: 19 · 2021: 30 · 2020: 17 · 2019: 16 · 2018: 16 · 2017: 12 · 2016: 20 · 2015: 23 · 2014: 14 · 2013: 20 · 2012: 15
- FWCI
- 13.41
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Molecular and Cellular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Royal Society
- Tenovus
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- NF-κB, p53, transcriptional crosstalk, RelA/p65, P300, CREB-binding protein, transcriptional coactivator, apoptosis, TNF-α, transcriptional repression, carcinogenesis
- MeSH terms
- Binding, Competitive, Cell Line, Gene Expression Regulation, Humans, Mutation, Repressor Proteins, Transcription, Genetic, Tumor Necrosis Factor-alpha, Ultraviolet Rays, Trans-Activators, Tumor Suppressor Protein p53, NF-kappa B, Apoptosis, Genes, Reporter, Transcription Factor RelA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review